Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-04-08 @ 5:34 PM
Study NCT ID:
NCT02114502
Status:
WITHDRAWN
Last Update Posted:
2014-07-11
First Post:
2014-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2018-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-04-11
First Submit QC Date:
None
Study First Post Date:
2014-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-09
Last Update Post Date:
2014-07-11
Last Update Post Date Type:
ESTIMATED